The global high blood pressure/hypertension drugs monitoring device market is anticipated to grow at a considerable CAGR of 5.8% during the forecast period (2024-2031). The market growth is mainly attributed to the increasing number of people leading a hectic lifestyle and rise in geriatric population across the globe. Sedentary lifestyle has resulted in increased consumption of alcohol and smoking, particularly in developed economies. Increase in importance of blood pressure monitoring devices in home care settings and emergence of advanced technologies have also contributed significantly towards the growth of the market. Moreover, the increase in obese population and improvement in awareness about the harmful effects of hypertension have fueled the market growth. However, lack of awareness about these devices in the low- and middle-income countries is use to hamper the market growth.
Get Free Sample link @ https://www.omrglobal.com/request-sample/hypertension-drugs-monitoring-device-market
Furthermore, the mortality rate associated with non-communicable diseases including cardiovascular disease, cancer, diabetes, and chronic lung diseases have surpassed that of infectious diseases. According to a report by WHO in 2018, about 17 million deaths are caused due to cardiovascular diseases every year, of which hypertension accounts for about 45% of the fatalities, with nearly 9.4 million deaths. Developed countries such as the US and Germany have been able to control the incidence of hypertension in recent years through implementation of strong public health policies. However, a large pool of individuals in economically weak countries suffer from heart attacks and strokes due to uncontrolled hypertension.
Full report of High Blood Pressure/Hypertension Drugs and Monitoring Device Market available @ https://www.omrglobal.com/industry-reports/hypertension-drugs-monitoring-device-market
Market Coverage
- Segment Covered-
o By Drugs
o By Monitoring Devices
o By End-user
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Hill-Rom Holdings, Inc., American Diagnostic Corporation, Boehringer Ingelheim International GmbH, Bayer AG, Koninklijke Philips N.V., GE Healthcare
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Report Segment
By Drugs
- Pulmonary Hypertension Drugs
- Systemic Hypertension Drugs
By Monitoring Devices
- Aneroid Sphygmomanometers
- Mercury Sphygmomanometer
- Digital Devices
- Ambulatory BP Monitors
By End-user
- Hospitals and Clinics
- Homecare
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hypertension-drugs-monitoring-device-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
